BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23318974)

  • 1. Decreased pool of mesenchymal stem cells is associated with altered chemokines serum levels in atrophic nonunion fractures.
    Mathieu M; Rigutto S; Ingels A; Spruyt D; Stricwant N; Kharroubi I; Albarani V; Jayankura M; Rasschaert J; Bastianelli E; Gangji V
    Bone; 2013 Apr; 53(2):391-8. PubMed ID: 23318974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of native mesenchymal stem cells from bone marrow and local tissue in an atrophic nonunion model.
    Tawonsawatruk T; Kelly M; Simpson H
    Tissue Eng Part C Methods; 2014 Jun; 20(6):524-32. PubMed ID: 24147916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The systemic angiogenic response during bone healing.
    Weiss S; Zimmermann G; Pufe T; Varoga D; Henle P
    Arch Orthop Trauma Surg; 2009 Jul; 129(7):989-97. PubMed ID: 19037648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human hypertrophic nonunion tissue contains mesenchymal progenitor cells with multilineage capacity in vitro.
    Iwakura T; Miwa M; Sakai Y; Niikura T; Lee SY; Oe K; Hasegawa T; Kuroda R; Fujioka H; Doita M; Kurosaka M
    J Orthop Res; 2009 Feb; 27(2):208-15. PubMed ID: 18752274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periosteal Mesenchymal Progenitor Dysfunction and Extraskeletally-Derived Fibrosis Contribute to Atrophic Fracture Nonunion.
    Wang L; Tower RJ; Chandra A; Yao L; Tong W; Xiong Z; Tang K; Zhang Y; Liu XS; Boerckel JD; Guo X; Ahn J; Qin L
    J Bone Miner Res; 2019 Mar; 34(3):520-532. PubMed ID: 30602062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities.
    Ponte AL; Marais E; Gallay N; Langonné A; Delorme B; Hérault O; Charbord P; Domenech J
    Stem Cells; 2007 Jul; 25(7):1737-45. PubMed ID: 17395768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages inhibit migration, metabolic activity and osteogenic differentiation of human mesenchymal stem cells in vitro.
    Chen C; Uludağ H; Wang Z; Rezansoff A; Jiang H
    Cells Tissues Organs; 2012; 195(6):473-83. PubMed ID: 22156615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Number and proliferative capacity of human mesenchymal stem cells are modulated positively in multiple trauma patients and negatively in atrophic nonunions.
    Seebach C; Henrich D; Tewksbury R; Wilhelm K; Marzi I
    Calcif Tissue Int; 2007 Apr; 80(4):294-300. PubMed ID: 17431529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient engineering of vascularized ectopic bone from human embryonic stem cell-derived mesenchymal stem cells.
    Domev H; Amit M; Laevsky I; Dar A; Itskovitz-Eldor J
    Tissue Eng Part A; 2012 Nov; 18(21-22):2290-302. PubMed ID: 22731654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma.
    Motaln H; Gruden K; Hren M; Schichor C; Primon M; Rotter A; Lah TT
    Cell Transplant; 2012; 21(7):1529-45. PubMed ID: 22554389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of GDF5 through an adenovirus vector stimulates osteogenesis of human mesenchymal stem cells in vitro and in vivo.
    Cheng X; Yang T; Meng W; Liu H; Zhang T; Shi R
    Cells Tissues Organs; 2012; 196(1):56-67. PubMed ID: 22287558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mesenchymal stem cell-derived cytokines on the functional properties of endothelial progenitor cells.
    Kamprom W; Kheolamai P; U-Pratya Y; Supokawej A; Wattanapanitch M; Laowtammathron C; Issaragrisil S
    Eur J Cell Biol; 2016; 95(3-5):153-63. PubMed ID: 26899034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whatever their differentiation status, human progenitor derived - or mature - endothelial cells induce osteoblastic differentiation of bone marrow stromal cells.
    Thébaud NB; Siadous R; Bareille R; Remy M; Daculsi R; Amédée J; Bordenave L
    J Tissue Eng Regen Med; 2012 Nov; 6(10):e51-60. PubMed ID: 22740324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial progenitor cells improve directly and indirectly early vascularization of mesenchymal stem cell-driven bone regeneration in a critical bone defect in rats.
    Seebach C; Henrich D; Wilhelm K; Barker JH; Marzi I
    Cell Transplant; 2012; 21(8):1667-77. PubMed ID: 22507568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative proteome approach demonstrates that platelet-derived growth factor C and D efficiently induce proliferation while maintaining multipotency of hMSCs.
    Sotoca AM; Roelofs-Hendriks J; Boeren S; van der Kraan PM; Vervoort J; van Zoelen EJ; Piek E
    Exp Cell Res; 2013 Oct; 319(17):2649-62. PubMed ID: 23933496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 2 inhibits up-regulation of bone morphogenic proteins and their receptors during osteoblastic differentiation of human mesenchymal stem cells.
    Biver E; Soubrier AS; Thouverey C; Cortet B; Broux O; Caverzasio J; Hardouin P
    Biochem Biophys Res Commun; 2012 Nov; 427(4):737-42. PubMed ID: 23044416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts.
    Massot A; Navarro-Sobrino M; Penalba A; Arenillas JF; Giralt D; Ribó M; Molina CA; Alvarez-Sabín J; Montaner J; Rosell A
    Cerebrovasc Dis; 2013; 35(1):81-8. PubMed ID: 23429001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation.
    Murphy MB; Blashki D; Buchanan RM; Yazdi IK; Ferrari M; Simmons PJ; Tasciotti E
    Biomaterials; 2012 Jul; 33(21):5308-16. PubMed ID: 22542609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of lymphatic endothelial cells from bone marrow mesenchymal stem cells with VEGFs.
    Wei L; Liu Y; Chen G; Fang Y; Song X; Dong P; Gao J; Liu R; Ding Z; Bi Y; Liu Z
    Lymphology; 2012 Dec; 45(4):177-87. PubMed ID: 23700764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of advanced glycation end products (AGEs) are inversely associated with the number and migratory activity of circulating endothelial progenitor cells in apparently healthy subjects.
    Ueda S; Yamagishi S; Matsui T; Noda Y; Ueda S; Jinnouchi Y; Sasaki K; Takeuchi M; Imaizumi T
    Cardiovasc Ther; 2012 Aug; 30(4):249-54. PubMed ID: 21884000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.